(Q36983662)

17 August 2017

1 reference

title

Will focal therapy become a standard of care for men with localized prostate cancer? (English)

1 reference

17 August 2017

1 reference

6

Mark Emberton

1 reference

17 August 2017

Hashim Uddin Ahmed

1

1 reference

17 August 2017

Doug Pendse

2

1 reference

17 August 2017

Rowland Illing

3

1 reference

17 August 2017

Clare Allen

4

1 reference

17 August 2017

Jan H P van der Meulen

5

1 reference

17 August 2017

language of work or name

1 reference

1 November 2007

1 reference

Nature Clinical Practice Oncology

17 August 2017

published in

1 reference

17 August 2017

volume

4

1 reference

17 August 2017

issue

11

1 reference

17 August 2017

page(s)

632-642

1 reference

Radiotherapeutic techniques for prostate cancer, dose escalation and brachytherapy

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

Can Power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

The physical burden of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Active surveillance for prostate cancer: for whom?

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Early outcomes of active surveillance for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

The changing face of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Evidence to support a continued stage migration and decrease in prostate cancer specific mortality

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Radical prostatectomy versus watchful waiting in early prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Prostate cancer pathologic stage pT2b (2002 TNM staging system): does it exist?

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Clinical and pathological characteristics of unstageable prostate cancer: analysis of the CaPSURE database

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Comparison of ultrasound-guided biopsies and prostatectomy specimens: predictive accuracy of Gleason score and tumor site

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Detailed mapping of prostate carcinoma foci: biopsy strategy implications

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Morphology of prostate cancer: the effects of multifocality on histological grade, tumor volume and capsule penetration.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Difference of cancer core distribution between first and repeat biopsy: In patients diagnosed by extensive transperineal ultrasound guided template prostate biopsy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

How Well Does the Gleason Score Predict Prostate Cancer Death? A 20-Year Followup of a Population Based Cohort in Sweden

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Should we replace the Gleason score with the amount of high-grade prostate cancer?

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Characterization of minute adenocarcinomas of prostate at radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Is tumor volume an independent prognostic factor in clinically localized prostate cancer?

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Gene promoter methylation in prostate tumor-associated stromal cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Expression of a novel biomarker, EPCA, in adenocarcinomas and precancerous lesions in the prostate.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Radical prostatectomy vs watchful waiting in early prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Pathological characteristics of prostate cancer detected through prostate specific antigen based screening

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Survival prospects after screen-detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Late gastrointestinal toxicity after radiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

A systematic overview of radiation therapy effects in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Have complication rates decreased after treatment for localized prostate cancer?

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Surgical management of prostate cancer: advances based on a rational approach to the data

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Vattikuti Institute prostatectomy: contemporary technique and analysis of results.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

The percentage of positive biopsy cores as a predictor of disease recurrence in patients with prostate cancer treated with radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

20-year outcomes following conservative management of clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Prostate carcinoma I: prognostic factors in radical prostatectomy specimens and pelvic lymph nodes

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Prostate carcinoma II: prognostic factors in prostate needle biopsies

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Natural History of Early, Localized Prostate Cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Treatment decisions for localized prostate cancer: asking men what's important

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Is 'watchful waiting' a real choice for men with prostate cancer? A qualitative study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Focal "nerve-sparing" cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Focal prostate cryoablation: initial results show cancer control and potency preservation

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Power Doppler ultrasonography-directed prostate biopsy in men with elevated serum PSA levels: an evaluation of the clinical utility and limitations

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

How good is MRI at detecting and characterising cancer within the prostate?

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis--correlation with biopsy and histopathology

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Dynamic Contrast Enhanced, Pelvic Phased Array Magnetic Resonance Imaging of Localized Prostate Cancer for Predicting Tumor Volume: Correlation With Radical Prostatectomy Findings

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

MAGNETIC RESONANCE IMAGING OF CLINICALLY LOCALIZED PROSTATIC CANCER

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Measurement of prostate rotation during insertion of needles for brachytherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Complications of transrectal versus transperineal prostate biopsy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Systematic transperineal ultrasound-guided template biopsy of the prostate: three-year experience.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Focal therapy in prostate cancer: future trends.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Visually directed high-intensity focused ultrasound for organ-confined prostate cancer: A proposed standard for the conduct of therapy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Are repeat biopsies required in men with PSA levels < or =4 ng/ml? A Multiinstitutional Prospective European Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Post-therapy changes in PSA as an outcome measure in prostate cancer clinical trials.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0959

7 January 2021

Identifiers

DOI

10.1038/NCPONC0959

1 reference

17 August 2017

1 reference